| Solly Silwan Chedid, MD | |
|
2809 Denny Ave, Pascagoula, MS 39581-5301 | |
| (228) 809-5251 | |
| (228) 809-5255 |
| Full Name | Solly Silwan Chedid |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 25 Years |
| Location | 2809 Denny Ave, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972586188 | NPI | - | NPPES |
| 09438250 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 29039 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Garden Park Medical Center | Gulfport, MS | Hospital |
| Singing River Health System | Pascagoula, MS | Hospital |
| Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singing River Gulfport | 5294154829 | 106 |
News Archive
Ceres, Inc., an agricultural biotechnology company focused on forage and feed crops, announced that its petition to have a number of its traits for corn deemed non-regulated has been successful.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.
Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris.
The number of health savings accounts (HSAs) and health reimbursement arrangements (HRAs) increased to 5.7 million in 2010, according to a new report by the nonpartisan Employee Benefit Research Institute (EBRI). Assets in these account-based health plans increased to $7.7 billion in 2010.
› Verified 1 days ago
| Entity Name | Singing River Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083893937 PECOS PAC ID: 3870405194 Enrollment ID: O20031104000435 |
News Archive
Ceres, Inc., an agricultural biotechnology company focused on forage and feed crops, announced that its petition to have a number of its traits for corn deemed non-regulated has been successful.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.
Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris.
The number of health savings accounts (HSAs) and health reimbursement arrangements (HRAs) increased to 5.7 million in 2010, according to a new report by the nonpartisan Employee Benefit Research Institute (EBRI). Assets in these account-based health plans increased to $7.7 billion in 2010.
› Verified 1 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
Ceres, Inc., an agricultural biotechnology company focused on forage and feed crops, announced that its petition to have a number of its traits for corn deemed non-regulated has been successful.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.
Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris.
The number of health savings accounts (HSAs) and health reimbursement arrangements (HRAs) increased to 5.7 million in 2010, according to a new report by the nonpartisan Employee Benefit Research Institute (EBRI). Assets in these account-based health plans increased to $7.7 billion in 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Solly Silwan Chedid, MD 2101 Highway 90, Gautier, MS 39553-5340 Ph: (228) 497-7576 | Solly Silwan Chedid, MD 2809 Denny Ave, Pascagoula, MS 39581-5301 Ph: (228) 809-5251 |
News Archive
Ceres, Inc., an agricultural biotechnology company focused on forage and feed crops, announced that its petition to have a number of its traits for corn deemed non-regulated has been successful.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.
Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris.
The number of health savings accounts (HSAs) and health reimbursement arrangements (HRAs) increased to 5.7 million in 2010, according to a new report by the nonpartisan Employee Benefit Research Institute (EBRI). Assets in these account-based health plans increased to $7.7 billion in 2010.
› Verified 1 days ago
Dr. Randy Roth, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5510 Fax: 228-809-5519 | |
James Lee Harwell, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5510 Fax: 228-809-5519 | |
Ediz Tasan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4300 Hospital St Ste 102, Pascagoula, MS 39581 Phone: 228-762-1002 | |
Dr. Edgar Hull, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Olusola Isikalu, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2712 Criswell Ave, Pascagoula, MS 39567 Phone: 228-762-0713 Fax: 228-762-0712 | |
Hugo A Quintana, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4211 Hospital St Ste 202, Pascagoula, MS 39581 Phone: 228-372-8270 Fax: 228-372-8270 | |
Thomas E. Stevens Jr., MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5510 Fax: 228-809-5519 |